NCT07600151 Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07390071 Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy Status RECRUITING Phase NA
NCT07297160 CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07206810 A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients Status COMPLETED Phase N/A
NCT07202091 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) Status RECRUITING Phase PHASE2/PHASE3
NCT07202078 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) Status RECRUITING Phase PHASE2/PHASE3
NCT07202065 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) Status RECRUITING Phase PHASE2/PHASE3
NCT07202052 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) Status RECRUITING Phase PHASE2/PHASE3
NCT07106671 A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma Status RECRUITING Phase PHASE2
NCT07052916 A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties Status RECRUITING Phase NA
NCT06947083 Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma Status RECRUITING Phase PHASE2
NCT06944119 Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06892119 Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT06518551 Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM Status RECRUITING Phase PHASE1/PHASE2
NCT06450821 PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications Status NOT_YET_RECRUITING Phase NA
NCT06430736 PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) Status RECRUITING Phase PHASE2